Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06554288 · ClinicalTrials.gov registry record · Phase 1
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
A Phase 1 study of Dystonia and Genetic Predisposition, sponsored by Children's Mercy Hospital Kansas City.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06554288 is a Phase 1 study of Dystonia and Genetic Predisposition that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 40 participants, below the 539-participant average among 28 other Dystonia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06554288, a Phase 1 study of Dystonia and Genetic Predisposition, is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks at how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy. The study aims to understand how trihexyphenidyl is broken down and used in the body of pediatric patients and whether this is impacted by a person's genetics. Information from this study will also be used to design future clinical trials.
Conditions Studied
Interventions
- DRUG Trihexyphenidyl
Study Locations (1)
Missouri
- Children's Mercy Hospital Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-15 |
| Est. Completion | 2029-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06554288
The ClinicalTrials.gov registry entry for NCT06554288 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 539-participant average among 28 other Dystonia trials with a reported enrollment target (93% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Dystonia appearing as the primary indexed condition, and to 1 intervention - of which Trihexyphenidyl is the first listed.
NCT06554288 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06554288 about?
NCT06554288 is a clinical study titled "Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy". This study looks at how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy. The study aims to understand how trihexyphenidyl is broken down and used in the body of pediatric patients and whether this is impacted by a person's genetics. Information from this study will a...
What is the current status of trial NCT06554288?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2024-10-15. Estimated completion is 2029-12-31.
What conditions does trial NCT06554288 study?
This clinical trial studies the following conditions: Dystonia, Genetic Predisposition, Pediatric Disorder, Pharmacogenomic Drug Interaction, Cerebral Palsy, Dyskinetic.
What interventions are being tested in trial NCT06554288?
The interventions under investigation include: Trihexyphenidyl (DRUG).
Who is sponsoring clinical trial NCT06554288?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06554288 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dystonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deep Brain Stimulation Surgery for Focal Hand Dystonia
ACTIVE NOT RECRUITING · Phase 1
-
Effects of Exercise on Dystonia Pathophysiology
RECRUITING · NA
-
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
RECRUITING
-
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
RECRUITING · NA
-
Dystonia Genotype-Phenotype Correlation
RECRUITING
-
Sleep-specific DBS Therapy in Parkinson's Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.